Rybelsus contains semaglutide, a GLP-1 receptor agonist that enhances insulin secretion and reduces glucagon release, aiding in blood glucose regulation. It's the first oral GLP-1 treatment, offering an alternative to injections. When combined with lifestyle modifications, Rybelsus effectively lowers HbA1c levels and may contribute to weight loss. Clinical studies have demonstrated its efficacy in improving glycemic control in adults with type 2 diabetes. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
